Multiple side effects of Efalizumab in a Saudi female with chronic persistent psoriasis followed by severe rebound after Efalizumab discontinuation

Authors

• Iqbal A. Bukhari, Associate Professor, Department of Dermatology, College of Medicine, King Fahad Hospital of the University, PO Box 40189, Al-Khobar 31952, Kingdom of Saudi Arabia. Tel. +966 (3) 8957886. Fax. +966 (3) 8949209. E-mail: consultant{at}dermatologyclinics.net

Abstract

We are reporting a case of 23-year-old Saudi female with persistent chronic plaque psoriasis who was given subcutaneous Efaluzimab 0.8 mg/kg/week for 14 weeks. During that period the patient developed multiple adverse reactions followed by severe rebound. The case is presented to highlight the importance of managing patients on Efalizumab carefully and closely.

Article Type

Case Report

First Page

1745

Last Page

1747

Recommended Citation

Bukhari, Iqbal A. (2007) "Multiple side effects of Efalizumab in a Saudi female with chronic persistent psoriasis followed by severe rebound after Efalizumab discontinuation," Saudi Medical Journal: Vol. 28: Iss. 11, Article 25.
DOI: https://doi.org/10.15537/1658-3175.4138